1 Study Coverage

• 1.1 Non-invasive Helicobacter Pylori Diagnostic Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2017-2022) & (US$ Million) Introduction
• 1.2 Global Non-invasive Helicobacter Pylori Diagnostic Outlook 2017 VS 2022 VS 2028
• 1.2.1 Global Non-invasive Helicobacter Pylori Diagnostic Market Size for the Year 2017-2028

1.2.2 Global Non-invasive Helicobacter Pylori Diagnostic Market Size for the Year 2017-2028

1.3 Non-invasive Helicobacter Pylori Diagnostic Market Size, United States VS Global, 2017 VS 2022 VS 2028

1.3.1 The Market Share of United States Non-invasive Helicobacter Pylori Diagnostic in Global, 2017 VS 2022 VS 2028

1.3.2 The Growth Rate of Non-invasive Helicobacter Pylori Diagnostic Market Size, United States VS Global, 2017 VS 2022 VS 2028

1.4 Non-invasive Helicobacter Pylori Diagnostic Market Dynamics

1.4.1 Non-invasive Helicobacter Pylori Diagnostic Industry Trends

1.4.2 Non-invasive Helicobacter Pylori Diagnostic Market Drivers

1.4.3 Non-invasive Helicobacter Pylori Diagnostic Market Challenges

1.4.4 Non-invasive Helicobacter Pylori Diagnostic Market Restraints

1.5 Study Objectives

1.6 Years Considered

2 Non-invasive Helicobacter Pylori Diagnostic by Type

• 2.1 Non-invasive Helicobacter Pylori Diagnostic Market Segment by Type
• 2.1.1 Invasive Techniques

2.1.2 Non-invasive Techniques

2.2 Global Non-invasive Helicobacter Pylori Diagnostic Market Size by Type (2017, 2022 & 2028)

2.3 Global Non-invasive Helicobacter Pylori Diagnostic Market Size by Type (2017-2028)

2.4 United States Non-invasive Helicobacter Pylori Diagnostic Market Size by Type (2017, 2022 & 2028)

2.5 United States Non-invasive Helicobacter Pylori Diagnostic Market Size by Type (2017-2028)

3 Non-invasive Helicobacter Pylori Diagnostic by Application

• 3.1 Non-invasive Helicobacter Pylori Diagnostic Market Segment by Application
• 3.1.1 Hospitals and Clinics

3.1.2 Diagnostic Laboratories

3.2 Global Non-invasive Helicobacter Pylori Diagnostic Market Size by Application (2017, 2022 & 2028)

3.3 Global Non-invasive Helicobacter Pylori Diagnostic Market Size by Application (2017-2028)

3.4 United States Non-invasive Helicobacter Pylori Diagnostic Market Size by Application (2017, 2022 & 2028)

3.5 United States Non-invasive Helicobacter Pylori Diagnostic Market Size by Application (2017-2028)

4 Global Non-invasive Helicobacter Pylori Diagnostic Competitor Landscape by Company

• 4.1 Global Non-invasive Helicobacter Pylori Diagnostic Market Size by Company
• 4.1.1 Top Global Non-invasive Helicobacter Pylori Diagnostic Companies Ranked by Revenue (2021)

4.1.2 Global Non-invasive Helicobacter Pylori Diagnostic Revenue by Player (2017-2022)

4.2 Global Non-invasive Helicobacter Pylori Diagnostic Concentration Ratio (CR)

4.2.1 Non-invasive Helicobacter Pylori Diagnostic Market Concentration Ratio (CR) (2017-2022)

4.2.2 Global Top 5 and Top 10 Largest Companies of Non-invasive Helicobacter Pylori Diagnostic in 2021

4.2.3 Global Non-invasive Helicobacter Pylori Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Non-invasive Helicobacter Pylori Diagnostic Headquarters, Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2017-2022) & (US$ Million) Type

4.3.1 Global Non-invasive Helicobacter Pylori Diagnostic Headquarters and Area Served

4.3.2 Global Non-invasive Helicobacter Pylori Diagnostic Companies Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2017-2022) & (US$ Million) Type

4.3.3 Date of International Companies Enter into Non-invasive Helicobacter Pylori Diagnostic Market

4.4 Companies Mergers & Acquisitions, Expansion Plans

4.5 United States Non-invasive Helicobacter Pylori Diagnostic Market Size by Company

4.5.1 Top Non-invasive Helicobacter Pylori Diagnostic Players in United States, Ranked by Revenue (2021)

4.5.2 United States Non-invasive Helicobacter Pylori Diagnostic Revenue by Players (2020, 2021 & 2022)

5 Global Non-invasive Helicobacter Pylori Diagnostic Market Size by Region

• 5.1 Global Non-invasive Helicobacter Pylori Diagnostic Market Size by Region: 2017 VS 2022 VS 2028
• 5.2 Global Non-invasive Helicobacter Pylori Diagnostic Market Size by Region (2017-2028)
• 5.2.1 Global Non-invasive Helicobacter Pylori Diagnostic Market Size by Region: 2017-2022

5.2.2 Global Non-invasive Helicobacter Pylori Diagnostic Market Size by Region (2023-2028)

6 Segment in Region Level & Country Level

• 6.1 North America
• 6.1.1 North America Non-invasive Helicobacter Pylori Diagnostic Market Size YoY Growth 2017-2028

6.1.2 North America Non-invasive Helicobacter Pylori Diagnostic Market Facts & Figures by Country (2017, 2022 & 2028)

6.1.3 United States

6.1.4 Canada

6.2 Asia-Pacific

6.2.1 Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Market Size YoY Growth 2017-2028

6.2.2 Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Market Facts & Figures by Region (2017, 2022 & 2028)

6.2.3 China

6.2.4 Japan

6.2.5 South Korea

6.2.6 India

6.2.7 Australia

6.2.8 China Taiwan

6.2.9 Indonesia

6.2.10 Thailand

6.2.11 Malaysia

6.3 Europe

6.3.1 Europe Non-invasive Helicobacter Pylori Diagnostic Market Size YoY Growth 2017-2028

6.3.2 Europe Non-invasive Helicobacter Pylori Diagnostic Market Facts & Figures by Country (2017, 2022 & 2028)

6.3.3 Germany

6.3.4 France

6.3.5 U.K.

6.3.6 Italy

6.3.7 Russia

6.4 Latin America

6.4.1 Latin America Non-invasive Helicobacter Pylori Diagnostic Market Size YoY Growth 2017-2028

6.4.2 Latin America Non-invasive Helicobacter Pylori Diagnostic Market Facts & Figures by Country (2017, 2022 & 2028)

6.4.3 Mexico

6.4.4 Brazil

6.4.5 Argentina

6.5 Middle East and Africa

6.5.1 Middle East and Africa Non-invasive Helicobacter Pylori Diagnostic Market Size YoY Growth 2017-2028

6.5.2 Middle East and Africa Non-invasive Helicobacter Pylori Diagnostic Market Facts & Figures by Country (2017, 2022 & 2028)

6.5.3 Turkey

6.5.4 Saudi Arabia

6.5.5 UAE

7 Company Profiles

• 7.1 Sekisui Diagnostics
• 7.1.1 Sekisui Diagnostics Company Details

7.1.2 Sekisui Diagnostics Business Overview

7.1.3 Sekisui Diagnostics Non-invasive Helicobacter Pylori Diagnostic Introduction

7.1.4 Sekisui Diagnostics Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2017-2022)

7.1.5 Sekisui Diagnostics Recent Development

7.2 F. Hoffmann-La Roche

7.2.1 F. Hoffmann-La Roche Company Details

7.2.2 F. Hoffmann-La Roche Business Overview

7.2.3 F. Hoffmann-La Roche Non-invasive Helicobacter Pylori Diagnostic Introduction

7.2.4 F. Hoffmann-La Roche Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2017-2022)

7.2.5 F. Hoffmann-La Roche Recent Development

7.3 Medline Industries

7.3.1 Medline Industries Company Details

7.3.2 Medline Industries Business Overview

7.3.3 Medline Industries Non-invasive Helicobacter Pylori Diagnostic Introduction

7.3.4 Medline Industries Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2017-2022)

7.3.5 Medline Industries Recent Development

7.4 Meridian Bioscience

7.4.1 Meridian Bioscience Company Details

7.4.2 Meridian Bioscience Business Overview

7.4.3 Meridian Bioscience Non-invasive Helicobacter Pylori Diagnostic Introduction

7.4.4 Meridian Bioscience Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2017-2022)

7.4.5 Meridian Bioscience Recent Development

7.5 Bio-Rad Laboratories

7.5.1 Bio-Rad Laboratories Company Details

7.5.2 Bio-Rad Laboratories Business Overview

7.5.3 Bio-Rad Laboratories Non-invasive Helicobacter Pylori Diagnostic Introduction

7.5.4 Bio-Rad Laboratories Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2017-2022)

7.5.5 Bio-Rad Laboratories Recent Development

7.6 Thermo Fisher Scientific

7.6.1 Thermo Fisher Scientific Company Details

7.6.2 Thermo Fisher Scientific Business Overview

7.6.3 Thermo Fisher Scientific Non-invasive Helicobacter Pylori Diagnostic Introduction

7.6.4 Thermo Fisher Scientific Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2017-2022)

7.6.5 Thermo Fisher Scientific Recent Development

7.7 Alpha Laboratories

7.7.1 Alpha Laboratories Company Details

7.7.2 Alpha Laboratories Business Overview

7.7.3 Alpha Laboratories Non-invasive Helicobacter Pylori Diagnostic Introduction

7.7.4 Alpha Laboratories Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2017-2022)

7.7.5 Alpha Laboratories Recent Development

7.8 EKF Diagnostics

7.8.1 EKF Diagnostics Company Details

7.8.2 EKF Diagnostics Business Overview

7.8.3 EKF Diagnostics Non-invasive Helicobacter Pylori Diagnostic Introduction

7.8.4 EKF Diagnostics Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2017-2022)

7.8.5 EKF Diagnostics Recent Development

7.9 Quidel

7.9.1 Quidel Company Details

7.9.2 Quidel Business Overview

7.9.3 Quidel Non-invasive Helicobacter Pylori Diagnostic Introduction

7.9.4 Quidel Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2017-2022)

7.9.5 Quidel Recent Development

7.10 Halyard Health

7.10.1 Halyard Health Company Details

7.10.2 Halyard Health Business Overview

7.10.3 Halyard Health Non-invasive Helicobacter Pylori Diagnostic Introduction

7.10.4 Halyard Health Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2017-2022)

7.10.5 Halyard Health Recent Development

7.11 Cardinal Health

7.11.1 Cardinal Health Company Details

7.11.2 Cardinal Health Business Overview

7.11.3 Cardinal Health Non-invasive Helicobacter Pylori Diagnostic Introduction

7.11.4 Cardinal Health Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2017-2022)

7.11.5 Cardinal Health Recent Development

7.12 Beckman Coulter

7.12.1 Beckman Coulter Company Details

7.12.2 Beckman Coulter Business Overview

7.12.3 Beckman Coulter Non-invasive Helicobacter Pylori Diagnostic Introduction

7.12.4 Beckman Coulter Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2017-2022)

7.12.5 Beckman Coulter Recent Development

7.13 Agilent Technologies

7.13.1 Agilent Technologies Company Details

7.13.2 Agilent Technologies Business Overview

7.13.3 Agilent Technologies Non-invasive Helicobacter Pylori Diagnostic Introduction

7.13.4 Agilent Technologies Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2017-2022)

7.13.5 Agilent Technologies Recent Development

7.14 Coris BioConcept

7.14.1 Coris BioConcept Company Details

7.14.2 Coris BioConcept Business Overview

7.14.3 Coris BioConcept Non-invasive Helicobacter Pylori Diagnostic Introduction

7.14.4 Coris BioConcept Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2017-2022)

7.14.5 Coris BioConcept Recent Development

8 Research Findings and Conclusion

9 Appendix

• 9.1 Research Methodology
• 9.1.1 Methodology/Research Approach

9.1.2 Data Source

9.2 Author Details

Market Analysis and Insights: Global and United States Non-invasive Helicobacter Pylori Diagnostic Market
This report focuses on global and United States Non-invasive Helicobacter Pylori Diagnostic market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Non-invasive Helicobacter Pylori Diagnostic market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Invasive Techniques accounting for % of the Non-invasive Helicobacter Pylori Diagnostic global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospitals and Clinics was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.

In United States the Non-invasive Helicobacter Pylori Diagnostic market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global Non-invasive Helicobacter Pylori Diagnostic Scope and Market Size

Non-invasive Helicobacter Pylori Diagnostic market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Non-invasive Helicobacter Pylori Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Non-invasive Helicobacter Pylori Diagnostic market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the Non-invasive Helicobacter Pylori Diagnostic market is segmented into

Invasive Techniques

Non-invasive Techniques

Segment by Application, the Non-invasive Helicobacter Pylori Diagnostic market is segmented into

Hospitals and Clinics

Diagnostic Laboratories

Regional and Country-level Analysis

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Landscape and Non-invasive Helicobacter Pylori Diagnostic Market Share Analysis

Non-invasive Helicobacter Pylori Diagnostic market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Non-invasive Helicobacter Pylori Diagnostic business, the date to enter into the Non-invasive Helicobacter Pylori Diagnostic market, Revenue in Non-invasive Helicobacter Pylori Diagnostic Business (2017-2022) & (US$ Million) introduction, recent developments, etc.

The major vendors covered:

Sekisui Diagnostics

F. Hoffmann-La Roche

Medline Industries

Meridian Bioscience

Bio-Rad Laboratories

Thermo Fisher Scientific

Alpha Laboratories

EKF Diagnostics

Quidel

Halyard Health

Cardinal Health

Beckman Coulter

Agilent Technologies

Coris BioConcept